Get the Stockscreener App
0.9757
3.40%
-0.0343
After Hours:
.97
-0.0057
-0.58%
Elutia Inc stock is traded at $0.9757, with a volume of 314.47K.
It is down -3.40% in the last 24 hours and down -16.61% over the past month.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
See More
Previous Close:
$1.01
Open:
$1.04
24h Volume:
314.47K
Relative Volume:
2.18
Market Cap:
$45.43M
Revenue:
$18.89M
Net Income/Loss:
$-20.44M
P/E Ratio:
-1.2387
EPS:
-0.7877
Net Cash Flow:
$-46.69M
1W Performance:
-2.43%
1M Performance:
-16.61%
6M Performance:
+1.64%
1Y Performance:
-48.65%
1-Day Range:
$0.95
$1.0499
1-Week Range:
$0.95
$1.08
52-Week Range:
$0.50
$2.64
Elutia Inc Stock (ELUT) Company Profile
Name
Elutia Inc
Sector
Industry
Phone
240-247-1143
Address
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
0.9757 | 47.03M | 18.89M | -20.44M | -46.69M | -0.7877 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-02-20 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-02-20 | Initiated | Cowen | Outperform |
| Nov-02-20 | Initiated | Piper Sandler | Overweight |
| Nov-02-20 | Initiated | Truist | Buy |
Elutia Inc Stock (ELUT) Latest News
Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 - The Manila Times
ELUT Elutia delivers blowout Q4 2025 EPS results, yet shares fall 1.83% in post-earnings trading.PEG Ratio - Newser
What factors are influencing Elutia (ELUT) stock | Q4 2025: EPS Beats ForecastsStock Market Community - Newser
Elutia (ELUT) Stock Movers | Q4 2025: EPS Tops ViewsTurnaround Phase - Cổng thông tin điện tử tỉnh Lào Cai
ELUT (Elutia Inc.) posts a profitable Q4 2025 EPS result that far exceeds Wall Street’s consensus loss estimates. - Xã Thanh Hà
Elutia (NASDAQ: ELUT) seeks approval for larger equity plan and board slate - Stock Titan
[ARS] ELUTIA INC. SEC Filing - Stock Titan
Elutia (ELUT) Stock Volume Cluster (Smart Money Exits) 2026-04-20Trending Entry Points - Cổng thông tin điện tử tỉnh Tây Ninh
ELUT (Elutia) delivers blowout Q4 2025 EPS results, with its stock price unchanged in trading today.ROA - Newser
Boston Scientific buys Elutia's bioenvelope business for $88 million - MSN
Elutia (ELUT) director receives 6,250 shares as RSUs vest, holding 125,000 - Stock Titan
Elutia Inc. (NASDAQ:ELUT) Q4 2025 earnings call transcript - MSN
Aug Retail: Is Elutia Inc forming a breakout patternTrend Reversal & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Quarterly Risk: Can Elutia Inc be recession proofWeekly Loss Report & Safe Entry Point Identification - baoquankhu1.vn
ELUT PE Ratio & Valuation, Is ELUT Overvalued - Intellectia AI
Growth Recap: Is Elutia Inc stock risky to hold nowEarnings Beat & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Sentiment Review: Is Elutia Inc forming a breakout pattern2026 Performance Recap & Technical Pattern Recognition Alerts - baoquankhu1.vn
Breakout Move: What is the Moat Score of Elutia IncTrade Analysis Summary & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Earnings Miss: Can Elutia Inc be recession proof2026 Technicals & Verified Momentum Stock Ideas - baoquankhu1.vn
If You Invested $1,000 in Elutia Inc. (ELUT) - Stock Titan
Earnings Beat: Can Elutia Inc generate free cash flow2026 Historical Comparison & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Elutia (ELUT) Q4 2025 Earnings Call Transcript - AOL.com
Forecast Cut: Is Elutia Inc subject to activist investor interest2026 Earnings Surprises & Low Risk High Reward Ideas - baoquankhu1.vn
Aug Technicals: Is Elutia Inc subject to activist investor interest2026 Price Momentum & Weekly Momentum Stock Picks - baoquankhu1.vn
Elutia to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19 - Bitget
Elutia to Present at Sidoti’s Small-Cap Virtual Investor Conference March 18-19 - The Manila Times
Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win - The Globe and Mail
Elutia Announces Grants of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Elutia (ELUT) Grants Stock Options to New Hires - GuruFocus
Elutia announces grants of inducement awards - TipRanks
Exit Recap: Is Elutia Inc subject to activist investor interest2026 Market Mood & Detailed Earnings Play Strategies - baoquankhu1.vn
Elutia 2025 10-K: Revenue $12.3M, EPS (cont. ops) $(15.871)M - TradingView
Elutia (NASDAQ: ELUT) pivots to drug‑eluting biomatrix after asset divestitures - Stock Titan
Achieving Micron-Level Tolerances: CAD Optimization for Sub-10µm 3D Printing - AOL.com
Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (RLAY), Stryker (SYK) and Elutia (ELUT) - The Globe and Mail
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - Bitget
Elutia markets another product for sale as it pivots to breast reconstruction infection prevention - The Business Journals
[Form 4] ELUTIA INC. Insider Trading Activity - Stock Titan
Elutia (ELUT) CEO receives stock from RSU vesting while shares withheld for taxes - Stock Titan
Elutia Q4 2025 slides: $88M sale funds pivot to breast reconstruction - Investing.com Australia
Elutia Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ELUT) 2026-03-12 - Seeking Alpha
Elutia Reports Strong 2025 Financial Results, Advances NXT-41x for Breast Cancer Surgery, and Closes $88M BioEnvelope Sale to Boston Scientific - Minichart
Elutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Moves Amid ... By GuruFocus - Investing.com Canada
Elutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Grow - GuruFocus
Elutia Inc Stock (ELUT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):